Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases.
Journal: JAMA oncology
Published: July 03, 2026
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery A Prospective Cohort Study: Erratum.
Journal: Annals of surgery
Published: April 09, 2026
The Landscape of Genomic and Socioeconomic Variables in Patients with Colorectal Cancer Based on Genetic Ancestry.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: January 12, 2026
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: December 04, 2025
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study.
Journal: NPJ precision oncology
Published: September 11, 2025
Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management.
Journal: Journal of the American Academy of Dermatology
Published: June 30, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer.
Journal: Annals of surgery
Published: March 24, 2025
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab.
Journal: JCO precision oncology
Published: August 23, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 25, 2024
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 25, 2024
Last Updated: 09/26/2026